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Background: Influenza A(H1N1)pdm09 virus infection in Norwegian pigs was largely subclinical. This study tested
the hypothesis that the infection causes negligible impact on pigs’ growth performance in terms of feed
conversion efficiency, daily feed intake, daily growth, age on reaching 100 kg bodyweight and overall feed intake. A
sample of 1955 pigs originating from 43 breeding herds was classified into five infection status groups;
seronegative pigs (n = 887); seropositive pigs (n = 874); pigs positive for virus at bodyweight between 33 kg and
60 kg (n = 123); pigs positive for virus at bodyweight between 61 kg and 80 kg (n = 34) and pigs positive for virus
at bodyweight between 81 kg and 100 kg (n = 37). Each pig had daily recordings of feed intake and bodyweight
from 33 kg to 100 kg. Marginal effects of the virus infection on the outcomes were estimated by multi-level linear
regression, which accounted for known fixed effects (breed, birthdate, average daily feed intake and growth phase)
and random effects (cluster effects of pig and herd).
Results: The seropositive and virus positive pigs had decreased (P value<0.05) growth performance compared to
seronegative pigs even though feed intake was not decreased. Reduced feed conversion efficiency led to lower
average daily growth, additional feed requirement and longer time needed to reach the 100 kg bodyweight. The
effects were more marked (P value<0.03) in pigs infected at a younger age and lasted a longer period. Despite
increased feed intake observed, their growth rates were lower and they took more time to reach 100 kg
bodyweight compared to the seronegative pigs.
Conclusion: Our study rejected the null hypothesis that the virus infection had negligible adverse effects on
growth performance of Norwegian pigs.
Keywords: Growth performance, Daily growth, Feed conversion efficiency, Longitudinal study, Multi-level regression
analysis, Random intercept model, Pigs, Feed intake, Influenza A(H1N1)pdm09 virusBackground
Respiratory diseases in pigs are serious concerns for pig
producers worldwide because they cause substantial eco-
nomic losses from increased mortality, reduced feed effi-
ciency and growth rate, increased time to reach market
weight, increased carcass condemnation at slaughter and
costs of treatment and vaccination [1]. Among the many
respiratory pathogens in pigs, swine influenza viruses
(SIVs) are ubiquitous in intensive pig farming, and can* Correspondence: chiek.er@vetinst.no
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unless otherwise stated.be primary agents in causing respiratory disease [2-4]. In
April 2009, a new influenza A virus, named influenza A
(H1N1)pdm09 emerged in North- and South-America.
It spread rapidly in humans and pigs and soon became
endemic in pig populations worldwide including Norway
[5-7]. Like other SIVs, this A(H1N1)pdm09 virus spreads
easily between pigs and can cause acute respiratory dis-
ease [8-10] characterized by high fever, depression, loss
of appetite, tachypnoea, abdominal breathing and cough-
ing [7]. Uncomplicated SIV infections cause low mortal-
ity (usually less than 1%), but morbidity can reach 100%
[7]. Respiratory disease caused by SIVs can be exacerbatedis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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gens of which Porcine Reproductive and Respiratory
Syndrome virus (PRRSV), Mycoplasma hyopneumo-
niae, Pasteurella multocida, and Actinobacillus pleur-
opnuemoniae are the most common. Such respiratory
diseases are most frequently detected in 10- to 22-week-old
pigs and are termed the porcine respiratory disease
complex [1,11].
As compared to other pig populations in the world,
Norwegian pigs have the favourable condition of being
free from many respiratory pathogens like PRRSV, por-
cine respiratory coronavirus and M. hyopneumoniae,
which are serious respiratory pathogens in almost all
pig producing countries. Up until 2009, the Norwegian
pig population had also been free from SIVs. However
in the autumn of 2009, the Norwegian pig population
experienced the first outbreak of influenza virus infec-
tion [12]. Pig farmers and farm workers infected with
influenza A(H1N1)pdm09 virus transmitted the virus to
the pigs [13,14]. Within a few months, one third of
Norwegian pig herds were positive for antibodies
against the virus [15]. Subsequent annual national sur-
veillance from 2010 to 2012 revealed that 41-50% of pig
herds were seropositive, indicating that the virus had
become endemic in the Norwegian pig population [12].
Farmers of positive herds reported mild or absence of
clinical signs in their pigs [16] in Norway and in other
parts of the world [7].
Although there have been studies investigating the
clinical signs, pathology and immunology related to
SIVs, including influenza A(H1N1)pdm09 virus infection
in pigs [2,9-11,17,18], there is little information available
on the adverse effects of influenza virus infection on
growth performance of pigs in the field. We therefore
aimed by using a field study to investigate the adverse ef-
fects of influenza A(H1N1)pdm09 virus on pig production
performance with longitudinal growth performance data
from a pig testing station between 2009 and 2012. Given
the mild clinical picture presented in previous studies
from Norway [14-16], the present study tested the hypoth-
esis that influenza A(H1N1)pdm09 virus has little or no
impact on growth performances in infected grower pigs.
The study also investigated whether the virus infection
had different impacts on Landrace and Duroc breeds, on
pigs infected at different ages, and the duration of the ad-
verse effects if present.
Methods
Boar testing station
During our period of investigation between 2009 and
2012, the boar testing station in Norway [19] had a cap-
acity of testing 1152 pigs in 16 separate rooms at the
same time. Each room housed a cohort of 72 pigs
grouped by breed (Landrace or Duroc) into six groupsof 12 pigs and placed in pens of 14 m2 in size. The sta-
tion received weekly, 72 growing pigs (11–12 weeks old
with a mean bodyweight of 33 kg) from 46 breeding
herds in Norway to monitor their growth performances
until they reached a bodyweight of 100 kg. Electronic feed-
ing stations in all pig pens used FIRE (Feed Intake Record-
ing Equipment, Osbourne Ltd, UK) to record daily feed
intake and daily weight gain of each pig individually. Pigs
fed one at a time ad libitum from one electronic feed dis-
penser in each pen on conventional concentrate contain-
ing 161 g and 136 g digestible protein, 9.68 MJ, and
9.50 MJ net energy/kg before and after 50 kg live weight,
respectively, with 1 month of mixing the two feeds to fa-
cilitate the feed change.
Study sample
The study sample consisted of 1955 pigs (55% Landrace,
45% Duroc) from 43 breeding herds that were perform-
ance tested at the testing station between 2009 and
2012. All pigs were tested for antibodies against influ-
enza A virus by cELISA before leaving the station. Dur-
ing a clinical outbreak of influenza at the boar station
between 1st April 2011 and 31st July 2011, nasal swabs
and blood samples were collected from a total of 375 of
these pigs (three pigs per pen) to test for presence of
virus and antibodies against the virus, respectively. The
testing methods have been described previously [15].
Based on laboratory findings, the 1955 pigs were classi-
fied into five infection status groups (INFGP). The sero-
negative group (SERONEG) with 887 pigs was defined
as pigs tested negative for antibodies against influenza
A(H1N1)pdm09 virus at the end of their performance
testing period. The seropositive group (SEROPOS)
with 874 pigs was defined as pigs tested positive for
antibodies against influenza A(H1N1)pdm09 virus but
with unknown point of infection. Most (n = 859) of
these pigs were tested at the end of the performance
testing period when they were about 100 kg in weight
thus ruling out maternal antibodies in cELISA test re-
sults. The virus positive group one (VIR1) with 123
pigs was defined as pigs tested positive for influenza A
(H1N1)pdm09 virus by RT-PCR when their body-
weight was between 33 kg and 60 kg (growth phase
one or GF1). Of these VIR1 pigs, twenty-two were in
the upper weight range of between 51 kg and 60 kg
when they were tested positive for the virus. The virus
positive group two (VIR2), with 34 pigs, was defined
as pigs tested positive for influenza A(H1N1)pdm09
virus by RT-PCR when their bodyweight was between
61 kg and 80 kg (growth phase two or GF2). The virus
positive group three (VIR3), with 37 pigs was defined
as pigs that tested positive for influenza A(H1N1)
pdm09 virus by RT-PCR when their bodyweight was
between 81 kg and 100 kg (growth phase three or
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of the bodyweights of these 194 virus positive pigs when
they were tested. These pigs were then classified into
three groups to ensure that there were at least 30 pigs
in each group.
During the period when the station experienced a
clinical outbreak of influenza A(H1N1)09pdm virus,
the staff intensified the clinical observation of the
2045 pigs that stayed at the station during this period.
The source of the outbreak was not investigated as the
infection has become widespread in the Norwegian
pig population since its incursion into Norway in
2009 [15].
Statistical analysis
Growth and feeding performances were represented by
five outcomes; average daily growth (ADG, weight gain
in kg/day), feed conversion efficiency (FCE, kg feed/kg
weight gain), average daily feed intake (ADFI, feed intake
in kg/day), age of pig when they reached 100 kg
(Age100kg) bodyweight; and the overall feed intake
(OFI) of the pigs to grow from a mean starting weight of
33 kg to 100 kg. Besides the infection status groups
(INFGP; SERONEG, SEROPOS, VIR1, VIR2 and VIR3)
as the main predictor of interest, important control pre-
dictors were birthdate (BD), breed (Br), ADFI, and GF.
For each of the three outcomes of ADG, FCE and ADFI,
every pig had three measures aggregated for the three
stipulated growth phases. The SERONEG pigs were the
reference group for comparison with the SEROPOS
group and the three virus positive groups. The data was
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Figure 1 Histogram of weight of virus positive pigs (n= 194) when thand feed intake [19] and was hierarchical with three
levels. The observations for each outcome were nested
in the 1955 pigs, which in turn were nested in the 43
herds. To estimate the negative effects of the virus in-
fection on growth performance, we used multi-level
random-intercept regression models to control for
other important predictors, while accounting for clus-
tering or random effects at the pig and herd levels [20].
We used analysis of covariance to determine the statis-
tical significance (P value<0.05 for level of inclusion) of
predictors for each of the five outcomes. Predictors BD
(proxy for improvement over time from 2009 to 2012)
and ADFI were continuous variables while INFGP, Br,
GF and two interaction terms of GF*INFGP and
Br*INFGP for stratification were categorical variables.
The INFGP*GF interaction term was included in the
regression model to investigate the modifying effect of
age of infection on the virus [21]. The INFGP*Br inter-
action term was tested for statistical significance to see
if the impact of the virus infection was different be-
tween Landrace and Duroc. The two outcomes,
Age100 kg and OFI, were single measures for each pig’s
overall performance when they reached 100 kg body-
weight. The predictors for them were the same as for
FCE and ADG, but without GF since the measures
were aggregated over all the 3 growth phases. To select
the best multi-level models for the five outcomes with
the selected predictors, we used Akaike Information
Criterion (AIC). We selected the model with the lowest
AIC value. To determine the significance of additional
predictors for each of the five models (one outcome
per model), a difference of ±2 of the AIC value was60 80 100
pigs (n=194) when tested
ey were tested positive for virus shedding.
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model was then chosen [22].
Multi-level random-intercept regression models
Y i;j;k½  ¼ β0þβ1X1 i;j;k½ þ… :: þβhXh i;j;k½  þu j;k½ þv k½  þε i;j;k½ :
Where:
Y is one of the five outcomes in this study (ADG, FCE,
ADFI, Age100kg, or OFI,). Yijk is the value of the re-
sponse for ith (i = 1,2,3) observation for jth pig (nj =
1955) nested within the kth (nk = 43) herd.
β is a vector of coefficients for predictors and their in-
teractions, and X[i,j,k] is the vector of explanatory vari-
ables for the ith observation of the jth pig and kth herd.
ujk is a vector of random intercepts unique to each pig in
each herd, where ujk~N(0, σ
2
pig), and vk is a vector of ran-
dom intercepts unique to each herd, where vk~N(0, σ
2
herd).
εijk is the vector of error terms where εijk ~N(μ, σ
2).
Predictors
Apart from BD and ADFI that are continuous predic-
tors, the following are categorical predictors:
INFGP: SERONEG; SEROPOS; VIR1; VIR2; VIR3.
Br: Landrace; Duroc
GF: GF1 (33 kg to 60 kg); GF2 (61 kg to 80 kg); GF3
(81 kg to 100 kg).
Quantitative bias analysis by Episens [23] was used to
estimate the magnitude of misclassification bias for
adverse effects on FCE given that the cELISA test had a
respective sensitivity and specificity of 93.7% and 99.1%
(manufacturer’s data sheet). A small number of mis-
classification of the 887 seronegative pigs and 874 sero-
positive pigs may have been possible. This required
dichotomizing the continuous outcome FCE into high
and low with median FCE value of 2.54 for the seronega-
tive pigs chosen for the dichotomy.
We used software SAS Enterprise Guide 4.3 (SAS
Institute Inc., Cary, NC, USA) and STATA version 12.0
(StataCorp LP, College Station, TX, USA) for data hand-
ling and statistical analysis. We plotted the predicted
marginal effects of the five infection status groups of
pigs (INFGP) for each of our five outcomes based on
our regression models by keeping the other covariates at
the sample mean values.
Ethics
This was a field study that involved pigs at a commercial
pig testing station. No pigs were harmed during the col-
lection of blood samples from the jugular vein or nasal
swabs to ascertain their infection status.Results
Statistical models
Based on AIC values and the parsimony principle,
Table 1 shows the final multi-level models for the five
outcomes. For outcomes ADG, FCE and ADFI, there
were three levels (5,865 observations, 1955 pigs, and 43
herds) in the hierarchy. For the remaining two out-
comes, Age100 kg and OFI, there were two levels (1955
observations and 43 herds) in the hierarchy. Only one
interaction term of interest, between infection status
and growth phase (INFGP*GF) was statistically signifi-
cant indicating that the effect of the virus varied with
the different growth phases. The second interaction of
practical interest between infection status and breed
(INFGP*Br), was found statistically insignificant during
model selection indicating that that effects of the virus
infection on Landrace and Duroc were similar or the
power was insufficient to reject the null hypothesis.
ADG and FCE
Tables 2, 3 and 4 show that with SERONEG pigs as the
reference, there were statistically significant marginal ad-
verse effects on ADG and FCE in all infected groups
(SEROPOS and VIRs 1–3). The marginal plots in
Figures 2 and 3 show the predicted means of ADG and
FCE while the covariates of BD, ADFI and Br were kept
at the sample means. Only GF and INFGP were allowed
to vary so that the effect of the virus infection on ADG
and INFGP could be studied in the three strata of
growth phases. The differences in the predicted FCE and
ADG between the five groups of pigs in each of the
three growth phases can then be attributed to infection
status of the pig.
For SEROPOS pigs, the negative effect on growth per-
formance was seen during GF3 where FCE was reduced
by +0.029 kg feed/kg weight gain. Correspondingly,
ADG also decreased by −0.015 kg/day.
For VIR1 pigs, adverse growth performance effects
were not seen until GF2 even though these pigs were
positive for virus during GF1. During GF2, FCE was re-
duced by +0.058 kg feed/kg weight gain, which led to a
lower ADG by −0.033 kg/day. These negative effects ex-
tended into GF3 where FCE was reduced by +0.125 kg
feed/kg weight gain and a corresponding lower ADG
by −0.058 kg/day.
Removing twenty-two oldes pigs in VIR1 pigs to to leave
101 younger pigs (VIR1a) that were viral positive when
they were 50 kg or less did not make any difference to the
results we saw in Table 3 in that the delayed adverse
effects were seen in GF2 and worsen in GF3 (Table 4).
For VIR2 and VIR3 pigs, the negative effects were
confined to the same growth phase that they were posi-
tive for virus. For VIR2 pigs during GF2, FCE was re-
duced by +0.122 kg feed/kg weight and ADG was lower
Table 1 Akaike information criterion (AIC) and the parsimony principle were used to select the best model for
each outcome














term INFGP*Br Pig Herd
ADG x x x x x x x x x -7157.8 -1.7
x x x x x x x x -7132.5 23.6
x x x x x x x x -7147.8 8.3
→ x x x x x x x x -7156.1 0
x x x x x x x x -7150 6.1
x x x x x x x -7149 7.1
FCE x x x x x x x x x -1889 3.7
x x x x x x x x -1769 123.7
x x x x x x x x -1878 14.7
→ x x x x x x x x -1892.7 0
x x x x x x x x -1864 28.7
x x x x x x x -1867 25.7
ADFI x x x x x x x x x 3299.8 2.8
x x x x x x x x 3564 267
x x x x x x x x 3307 10
→ x x x x x x x x 3297 0
x x x x x x x x 3304 7
x x x x x x x 3302 5
Age 100 kg x x x x x x 13111 5
x x x x x 13205.5 99.5
→ x x x x x 13106 0
OFI x x x x x x 15281 3
x x x x x 15362 84
→ x x x x x 15278 0
Abbreviations: ADG average daily growth in kg/day, FCE feed conversion efficiency in kg feed/kg weight gain, ADFI average daily feed intake in kg/day, Age 100 kg
age of pig when they reached 100 kg, OFI overall feed intake in kg from 33 kg to 100 kg bodyweight.
Selected model is indicated by (→). Marking X indicates predictor was included in the model. ΔAIC = difference in AIC between the tested models and the
selected model given in bold.
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of VIR2 pigs returned to the same levels as seronegative
pigs during GF3. For VIR3 pigs during GF3, the FCE
was reduced by +0.091 kg feed/kg weight gain and ADG
was lower by −0.045 kg/day correspondingly.
Average daily feed intake
Surprisingly we saw in Table 5 that there was no signifi-
cant decrease in ADFI for the four infected groups
(seropositive group and the three virus positive groups)
since anorexia was listed as one of the clinical signs in
pigs infected with SIVs. It was also interesting to observe
that VIR1 pigs had increased feed intake during the post
viral shedding period. Their average daily feed intake in-
creased by 71 g/day and 0.104 kg/day during GF2 and
GF3 respectively.Age of pigs at 100 kg
Consequent to the reduced FCE and hence lower ADG,
the virus positive pigs required longer time to reach the
bodyweight of 100 kg (Figure 4 and Table 6). The VIR1,
VIR2 and VIR3 pigs were slower by 1.6 days, 1.8 days and
2.4 days, respectively, in reaching 100 kg bodyweight. Al-
though VIR2 was statistically insignificant (P value = 0.12),
it was on similar trajectory as VIR1 and VIR3.
Overall feed intake
Consequent to the reduced FCE experienced by the four
infected groups, Figure 5 and Table 7 show that all four
infected groups needed additional feed to reach 100 kg
bodyweight. The SEROPOS, VIR1, VIR2 and VIR3 pigs
needed 2.3 kg, 8.0 kg, 5.9 kg and 7.2 kg additional feed,
respectively.
Table 2 Multilevel regression of average daily growth in pigs infected with influenza A(H1N1)pdm09 virus
Average Daily Growth (ADG)
Predictors Coefficients SE P values 95% CI
Breed
Landrace Reference
Duroc −0.028 0.006 <0.001 −0.039 −0.016
Growth phase
GF1 (33_60 kg) Reference
GF2 (61_80 kg) −0.062 0.0071 <0.001 −0.08 −0.05
GF3 (81_100 kg) −0.134 0.0083 <0.001 −0.15 −0.12
Birthdate 0.00006 0.000006 <0.001 0.00005 0.00007
Average daily feed intake 0.31 0.0053 <0.001 0.30 0.32
Interaction term: INFGP*GF
SERONEG*GF(1–3) Reference
SEROPOS*GF1 0.006 0.0064 0.37 −0.01 0.02
SEROPOS*GF2 −0.004 0.0064 0.54 −0.02 0.01
SEROPOS*GF3 −0.015 0.0064 0.02 −0.03 0.00
VIR1*GF1 0.008 0.0127 0.51 −0.02 0.03
VIR1*GF2 −0.033 0.0127 0.01 −0.06 −0.01
VIR1*GF3 −0.058 0.0127 <0.001 −0.08 −0.03
VIR2*GF1 0.002 0.0230 0.94 −0.04 0.05
VIR2*GF2 −0.053 0.0230 0.02 −0.10 −0.01
VIR2*GF3 −0.015 0.0230 0.51 −0.06 0.03
VIR3*GF1 0.014 0.0221 0.52 −0.03 0.06
VIR3*GF2 −0.020 0.0221 0.37 −0.06 0.02
VIR3*GF3 −0.045 0.0221 0.04 −0.09 0.00
Constant (β0) −0.746 0.1113 <0.001 −0.96 −0.53
Abbreviations: SERONEG Seronegative pigs; SEROPOS Seropositive pigs (not tested for virus), VIR1 pigs viral positive between bodyweight 33 kg and 60 kg,
VIR2 pigs viral positive between bodyweight 61 kg and 80 kg, VIR3 pigs viral positive between bodyweight 81 kg and 100 kg.
The model is hierarchical with three levels; observations (n = 5865); pig (n = 1955) and herd (n = 43). *denotes interaction term.
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the models
The predictors birthdate, breed and growth phase were
highly significant (P value<0.001) in our regression models
for all five outcomes). For birthdate as a predictor, the out-
comes of ADG, FCE, ADFI, Age100kg and OFI of pigs
improved each year or every 365 days by 0.022 kg body-
weight/day, −0.055 kg feed/kg bodyweight, −0.007 kg
feed/day, −2.2 days and −6.2 kg feed respectively.
On breed differences, Landrace pigs grew faster (ADG
of +0.028 kg/day), had better efficiency in feed conversion
(FCE was improved by −0.043 kg feed/kg bodyweight),
reached the targeted weight seven days earlier, and required
less feed (−5.9 kg feed) to reach 100 kg bodyweight.
Clinical observations between April and July 2011
During a clinical outbreak at the station from April 2011
to July 2011, a group 2045 pigs present at the station
were monitored closely for clinical signs. These pigsentered the station at different time since the station re-
ceived 72 new pigs on a weekly basis. Influenza-like ill-
ness was observed in 137 pigs, giving a crude morbidity
of 7%. Clinical signs observed were transient anorexia or
lethargy (45%), respiratory signs (coughing, laboured
breathing or nasal discharge, 39%), and pyrexia (above
39°C, 27%). The prevalence of these clinical signs re-
corded within each of the 16 rooms ranged from 0% to
17%. For group specific morbidity, clinical signs were not
detected in VIR1 pigs, while one (3%) out of 34 VIR2 pigs
and five (14%) out of 37 VIR3 pigs had clinical signs re-
ported. In the seropositive group, 39 (10%) out of 381 pigs
had clinical signs of influenza-like illness during the test-
ing period. No clinical signs were reported in the SERO-
NEG pigs.
Discussion
The findings in our study support the alternate hypoth-
esis that despite being a largely subclinical disease (<4%
Table 3 Multilevel regression of feed conversion
efficiency in pigs infected with influenza A(H1N1)pdm09
virus
Feed Conversion Efficiency (FCE)
Predictors Coefficients SE P value 95% CI
Breed
Landrace Reference
Duroc 0.0426 0.010 <0.001 0.0230 0.0622
Growth phase
GF1(33_60 kg) Reference
GF2(61_80 kg) 0.2865 0.011 <0.001 0.26 0.31
GF3(81_100 kg) 0.5442 0.014 <0.001 0.52 0.57
Birthdate -0.0002 0.00001 <0.001 -0.0002 -0.0001
Average daily feed
intake 0.0238 0.010 0.019 0.004 0.044
Interaction term: INGP*GF
SERONEG*GF(1-3) Reference
SEROPOS*GF1 -0.015 0.011 0.159 -0.037 0.006
SEROPOS*GF2 0.002 0.010 0.849 -0.018 0.022
SEROPOS*GF3 0.029 0.010 0.004 0.010 0.049
VIR1*GF1 -0.001 0.023 0.951 -0.046 0.043
VIR1*GF2 0.058 0.020 0.004 0.018 0.097
VIR1*GF3 0.125 0.020 <0.001 0.086 0.165
VIR2*GF1 -0.049 0.037 0.189 -0.121 0.024
VIR2*GF2 0.122 0.036 0.001 0.051 0.192
VIR2*GF3 0.033 0.036 0.361 -0.038 0.103
VIR3*GF1 -0.016 0.037 0.659 -0.089 0.056
VIR3*GF2 0.045 0.035 0.196 -0.023 0.112
VIR3*GF3 0.091 0.035 0.008 0.023 0.159
Constant (β0) 4.6609 0.1934 <0.001 4.282 5.040
Abbreviations: SERONEG Seronegative pigs, SEROPOS Seropositive pigs (not
tested for virus), VIR1 pigs viral positive between bodyweight 33 kg and 60 kg,
VIR2 pigs viral positive between bodyweight 61 kg and 80 kg, VIR3 pigs viral
positive between bodyweight 81 kg and 100 kg. The model is hierarchical
with three levels; observations (n = 5865); pig (n = 1955) and herd (n = 43).
*denotes interaction term.
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pdm09 virus infection reduced the pigs’ growth perform-
ance in terms of FCE and hence ADG. Consequently the
infected pigs needed more time to reach 100 kg and
additional feed was also consumed. The negative growth
performance effects were most evident in the pigs that
were infected at a young age, as shown by the VIR1 pigs.
The negative effects of reduced FCE and ADG in VIR1
extended into growth phases two and three. That was
beyond the viral shedding period of SIVs of about seven
days [7]. We have no explanation why adverse effects in
growth performance appeared only during the post viral
period and lasted longer in these VIR1 pigs that were in-
fected at bodyweight before 60 kg bodyweight. The dur-
ation of negative effects were shorter in the pigs infectedat a later age as represented by VIR2 pigs. Negative effects
in these pigs were limited to GF2, the same growth phase
that they were tested positive for the virus. Twenty two of
the 123 VIR1 pigs were in the upper weight range of 50 kg
and 60 kg. If these pigs were in the early viral shedding
period of 7 days during testing, shedding of virus and pre-
sumably the manifestation of adverse effects on growth
performance could cross over to the next growth phase
(61-80 kg). Misclassication bias could then result in con-
cluding the delayed and extended negative effects of the
virus infection on FCE in VIR1 pigs (Table 3). However in
our bias analysis (Table 4), the removal of these twenty-
two heavier pigs, from VIR1 and leaving 101 younger pigs
(VIR1a) that shed virus between 33 kg and 50 kg did not
change the result. Just as in the original VIR1 group of
123 pigs, the adverse effects on growth performance of
these 101 younger pigs (VIR1a) appeared during the post
viral period of growth phase two (61 -80 kg) and deterio-
rated during growth phase three (81 -100 kg).
Interestingly, none of the infected groups had depressed
average feed intake in any of the three growth phases as
we expected because anorexia is listed as one of the clin-
ical signs in pigs infected with the classical SIVs. Instead
the pigs infected at a young age (VIR1) ate more during
growth phases two and three, which were the post viral
shedding period for VIR1 pigs. Even though they increased
their feed intake, it was insufficient to compensate for the
reduced FCE during growth phases 2 and 3 to raise their
daily growth high enough to catch up with the seronega-
tive pigs. Consequently the overall feed intake of these
VIR1 pigs increased by 8 kg but were still slower by
1.6 days in getting to 100 kg bodyweight. Despite their
lower FCE, the increased appetite of VIR1 pigs during the
post viral shedding period of GF2 and GF3 was enough to
allow them to reach the bodyweight of 100 kg earlier than
VIR2 and VIR3 pigs which were infected at a later age.
Landrace and Duroc are the two major breeds in
Norway. The proportions of both breeds were almost
equal in our study. Even though there were intrinsic
breed differences in growth profile with Landrace having
a better feed conversion efficiency and higher daily feed
intake and hence higher daily growth, our investigation
found no differential adverse effects on growth perform-
ance caused by this virus infection on the two breeds.
Although the time period of infection for the 874 pigs in
the SEROPOS group were unknown, these pigs could have
been infected at any time during their growth phase before
or after arriving at the boar station. Blood for cELISA tests
were collected from these pigs when they were about
100 kg. With the exception of five pigs (67 days for the
youngest) in the SEROPOS group, the remaining 869 pigs
were older than 12 weeks when they were tested for anti-
bodies. It was therefore unlikely that they harboured de-
tectable maternal antibodies [24-26] at the time of testing.
Table 4 Multilevel regression of feed conversion efficiency in pigs infected with influenza A(H1N1)pdm09 virus
Feed Conversion Efficiency (FCE)
Predictors Coefficients SE P values 95% CI
Breed
Landrace Reference
Duroc 0.042 0.010 <0.001 0.023 0.062
Growth phase
GF1(33_60 kg) Reference
GF2(61_80 kg) 0.287 0.011 <0.001 0.264 0.309
GF3(81_100 kg) 0.544 0.014 <0.001 0.517 0.571
Birthdate -0.0002 0.00001 <0.001 0.000 0.000
Average daily feed intake 0.024 0.010 0.02 0.004 0.044
Interaction term: INFGP
SERONEG*GF(1-3) Reference
SEROPOS*GF1 -0.015 0.011 0.1570 -0.037 0.006
SEROPOS*GF2 0.002 0.010 0.8560 -0.018 0.022
SEROPOS*GF3 0.029 0.010 0.0040 0.009 0.049
VIR1a*GF1 -0.008 0.025 0.7510 -0.057 0.041
VIR1a*GF2 0.050 0.022 0.0230 0.007 0.093
VIR1a*GF3 0.114 0.022 0.0000 0.071 0.157
VIR1b*GF1 0.026 0.049 0.5930 -0.070 0.122
VIR1b*GF2 0.092 0.044 0.0390 0.005 0.178
VIR1b*GF3 0.176 0.045 0.0000 0.087 0.265
VIR2*GF1 -0.049 0.037 0.1870 -0.122 0.024
VIR2*GF2 0.121 0.036 0.0010 0.051 0.192
VIR2*GF3 0.033 0.036 0.3640 -0.038 0.103
VIR3*GF1 -0.016 0.037 0.6560 -0.089 0.056
VIR3*GF2 0.045 0.035 0.1970 -0.023 0.112
VIR3*GF3 0.091 0.035 0.0090 0.023 0.159
Constant (β0) 4.658 0.193 <0.001 4.279 5.037
Abbreviations: SERONEG Seronegative pigs, SEROPOS Seropositive pigs (not tested for virus), VIR1a pigs viral positive between bodyweight 33 kg and 50 kg, VIR1b
pigs viral positive between bodyweight 51 kg and 60 kg, VIR2 pigs viral positive between bodyweight 61 kg and 80 kg, VIR3 pigs viral positive between
bodyweight 81 kg and 100 kg. The model is hierarchical with three levels; observations (n = 5865); pig (n = 1955) and herd (n = 43). *denotes interaction term.
Er et al. BMC Veterinary Research  (2014) 10:284 Page 8 of 14The observation that the SEROPOS pigs had similar re-
sults to the 37 virus positive pigs in the VIR3 group in that
the adverse effect on FCE and ADG occurred during GF3
points to the possibility that the majority of seropositive
pigs were infected at the older age like VIR3 pigs. Al-
though these SEROPOS pigs reached 100 kg bodyweight
at the same time as the SERONEG pigs, these SEROPOS
pigs had reduced FCE during growth phase three which
resulted in these pigs consuming an additional 2 kg feed
to reach the bodyweight of 100 kg.
Bias analysis on misclassification
The cELISA test had a sensitivity and specificity of
93.7% and 99.1% (Manufacterers data sheets). Although
these values are considered high for test performance,
given the largely lack of clinical picture in this diseasefor corroboration, there could nevertheless be a small
number of SERONEG and SEROPOS pigs that were
misclassified and hence biased the adverse effects to-
wards the null. Our quantitative bias analysis using Epi-
sens [23] for adverse effects on a dichotomized FCE
showed that the odds ratio for a poorer FCE if the pig
was SEROPOS versus SERONEG was 1.13. The odds ra-
tio after adjusting for misclassification bias was 1.3, a
change of 2 percent. The small bias of 2 percent in our
study was towards the null (OR= 1).
The literature [7] states that SIVs in general, cause near
if not 100% morbidity when they infect naïve pigs. An ex-
perimental study with influenza A(H1N1)pdm09 virus by
Brookes et al. in 2010 [9] reported 100% morbidity involv-
ing 19 pigs in their experimental study, where 2 pigs were
























SERONEG SEROPOS VIR1 VIR2 VIR3
Infection status group
GF1 (33_60kg) GF2 (61_80kg) GF3 (81_100kg)
*All other covariates in model fixed at sample means
Figure 2 Marginal plots for average daily growth (ADG) and adverse effects of influenza A(H1N1)pdm09 virus infection. Based on the
model presented in Table 2, the mean ADG was predicted for each of the five infection status groups and the three growth phases (GF), while all
other covariates of birthdate, feed intake and breed were fixed at the sample means. The effect of the virus infection is marked by comparing the
four infected groups with the reference seronegative group on the same growth phase denoted by the line joining the groups. Comparisons
between groups were made for each growth phase since ADG vary with age. As depicted in the graph, the younger pigs would hypothetically
have a higher ADG because they have a better FCE (see Figure 2 and Table 3) if feed intake is fixed at the same level. The gradient of the lines
joining the means of each group and the confidence intervals indicate whether there were differences between the groups. Abbreviations:
INFGP = Infection status group; SEROPOS = seropositive pigs, SERONEG = seronegative pigs, VIR1 = PCR-positive pigs at bodyweight between
33 kg and 60 kg (GF1); VIR2 = PCR-positive pigs at bodyweight between 61 kg and 80 kg (GF2); VIR3 = PCR-positive pigs at bodyweight between


































SERONEG SEROPOS VIR1 VIR2 VIR3
Infection status group
GF1 (33_60kg) GF2 (61_80kg) GF3 (81 _100kg)
* All other covariates in model fixed at sample means
Figure 3 Marginal plots for feed conversion efficiency (FCE) and adverse effects of influenza A(H1N1)pdm09 virus infection. Based on
the model presented in Table 3, the mean FCE was predicted for each of the five infection status groups and the three growth phases (GF) while
all the other covariates of birthdate, feed intake and breed were fixed at the sample means. The effect of the virus infection is marked by
comparing the four infected groups with the reference seronegative group on the same growth phase as denoted by the line joining the
groups. Comparisons were made for each growth phase since feed efficiency decreases with age. The gradient of the lines joining the means of
each group and the confidence intervals indicate whether there were differences between the groups. Abbreviations: INFGP = Infection status
group; SEROPOS = seropositive pigs, SERONEG = seronegative pigs, VIR1 = PCR-positive pigs at bodyweight between 33 kg and 60 kg (GF1);
VIR2 = PCR-positive pigs at bodyweight between 61 kg and 80 kg (GF2); VIR3 = PCR-positive pigs at bodyweight between 81 kg and 100 kg (GF3).
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Table 5 Multilevel regression of average daily feed intake in pigs infected with influenza A(H1N1)pdm09 virus
Average daily feed intake (ADFI)
Predictors Coefficients SE P values 95% CI
Breed
Landrace Reference
Duroc −0.10 0.0157 <0.001 −0.13 −0.07
Growth Phase
GF1(33_60 kg) Reference
GF2(61_80 kg) 0.71 0.0136 <0.001 0.68 0.74
GF3(81_100 kg) 1.08 0.0136 <0.001 1.05 1.10
Birthdate −0.00002 0.00002 0.257 −0.00005 0.00001
Interaction term: INFGP*GF
SERONEG*GF(1–3) Reference
SEROPOS*GF1 −0.003 0.016 0.851 −0.034 0.028
SEROPOS*GF2 0.022 0.016 0.166 −0.009 0.053
SEROPOS*GF3 0.017 0.016 0.278 −0.014 0.049
VIR1*GF1 −0.024 0.032 0.444 −0.086 0.038
VIR1*GF2 0.071 0.032 0.025 0.009 0.133
VIR1*GF3 0.104 0.032 0.001 0.042 0.166
VIR2*GF1 0.077 0.057 0.176 −0.035 0.190
VIR2*GF2 0.032 0.057 0.574 −0.080 0.144
VIR2*GF3 0.070 0.057 0.223 −0.042 0.182
VIR3*GF1 0.059 0.055 0.283 −0.049 0.167
VIR3*GF2 0.077 0.055 0.164 −0.031 0.184
VIR3*GF3 −0.085 0.055 0.122 −0.193 0.023
Constant (β0) 1.897 0.3107 <0.001 1.288 2.506
Abbreviations: SERONEG Seronegative pigs, SEROPOS Seropositive pigs (not tested for virus), VIR1 pigs viral positive between bodyweight 33 kg and 60 kg,
VIR2 pigs viral positive between bodyweight 61 kg and 80 kg, VIR3 pigs viral positive between bodyweight 81 kg and 100 kg.
The model is hierarchical with three levels; observations (n = 5865); pig (n = 1955) and herd (n = 43). *denotes interaction term.
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Norwegian pigs was largely subclinical, with only six
(<4%) in a sample of 194 virus positive pigs reported to
have clinical signs. Apart from coughing, clinical signs, like
nasal discharge, were so mild that only through closer ob-
servation or handling of the pig, for example nasal swab-
bing, could the signs be detected. The mild clinical signs
and low morbidity recorded during the observation period
were similar to the morbidity experienced by other
Norwegian pig farms infected with influenza A(H1N1)
pdm09 virus for the first time [15,16]. This shows that
despite Norwegian pigs having no cross-protective im-
munity [27] to other strains of SIVs, the A(H1N1)pdm09
virus experienced in Norwegian pigs appeared to be of low
pathogenicity that caused no or only mild clinical signs.
In recording the clinical signs at the pig testing station,
possible bias of focusing on pigs with anorexia (shown on
the computer records) may have led to underestimating
the morbidity of the disease because we found no statisti-
cally significant decrease in appetite in the infected pigs inthe stipulated three growth phases. A transient drop in ap-
petite for one or two days would be masked by the three
growth phases since the intervals in each growth phase
were longer than two days and if there were compensatory
increases in feed intake following one or two days of de-
pressed feed intake.
Favourable conditions in our study
Pigs in our study did not have co-infections of other sub-
types of influenza A viruses, M. hyopneumoniae, PRRSV,
Aujesky’s disease virus and porcine respiratory corona-
virus, given Norway’s disease free status for these patho-
gens [12]. Secondly, the daily recordings of feed intake
and bodyweight for each pig were computerised without
the presence of human interference. This ruled out human
bias or error in making measurements to provide accurate
calculations of the performance parameters. Thirdly, the
repeated measures allowed the study of progressive effects
of the virus in pigs infected at different ages and also the




















SERONEG SEROPOS VIR1 VIR2 VIR3
Infection status group
* All other covariates in model firxed at sample means
Figure 4 Marginal plots of mean age at 100 kg and adverse effects of influenza A(H1N1)pdm09 virus infection. The plots show the
predicted mean ages of pigs at 100 kg for the five groups of pigs based on the model presented in Table 6. The gradient of the line joining the
mean for each group and the confidence intervals indicate whether there is any difference between the groups due to their infection status.
Comparisons were made between the four infected groups and the reference seronegative group. Abbreviations: INFGP = Infection status group;
SEROPOS = seropositive pigs, SERONEG = seronegative pigs, VIR1 = PCR-positive pigs at bodyweight between 33 kg and 60 kg (GF1); VIR2 = PCR-
positive pigs at bodyweight between 61 kg and 80 kg (GF2); VIR3 = PCR-positive pigs at bodyweight between 81 kg and 100 kg (GF3).
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With 34 or more pigs in each of the five groups of pigs,
the sample sizes are considered large for multi-level
models [28]. The five statistical models were based on
maximum likelihood in estimating the predictors that
allow for inference to the Norwegian pig population.
It was appropriate to use multi-level analysis because
of the hierarchical nature of the data. The data, having
5865 observations nested in the 1955 pigs, which in turnTable 6 Multilevel regression of pig’s age at 100 kg if they ar













Constant (β0) 316.8 9.4
Abbreviations: SERONEG Seronegative pigs, SEROPOS Seropositive pigs (not tested fo
VIR2= pigs viral positive between bodyweight 61 kg and 80 kg, VIR3 pigs viral posit
The model is hierarchical with two levels; pig (n = 1955) and herd (n = 43).were nested in the 43 herds, were handled to account
for the variations between individual pigs and between
the various herds including unmeasured confounders
like other infections at the herd or individual level. Pigs
from the study sample of 43 herds were represented in
the reference group of 887 seronegative pigs. Conse-
quently, the effects of virus infection (primary predictor
of interest) and the known covariates (predictors we
wanted to control) were more accurately estimated. Suche infected with influenza A(H1N1)pdm09 virus
P values 95% CI
<0.001 5.7 9.0







r virus), VIR1 pigs viral positive between bodyweight 33 kg and 60 kg;


















SERONEG SEROPOS VIR1 VIR2 VIR3
Infection status group
Figure 5 Marginal plots of overall feed intake and adverse effects of influenza A(H1N1)pdm09 virus infection. The plots show the
predicted mean overall feed intakes for the five groups of pigs based on the model presented in Table 7. The gradient of the line joining the
mean for each group and the confidence intervals indicate whether there is any difference between the groups due to their infection status.
Comparisons were made between the four infected groups and the reference seronegative group. Abbreviations: INFGP = Infection status group;
SEROPOS = seropositive pigs, SERONEG = seronegative pigs, VIR1 = PCR-positive pigs at bodyweight between 33 kg and 60 kg (GF1); VIR2 =
PCR-positive pigs at bodyweight between 61 kg and 80 kg (GF2); VIR3 = PCR-positive pigs at bodyweight between 81 kg and 100 kg (GF3).
Er et al. BMC Veterinary Research  (2014) 10:284 Page 12 of 14hierarchical models solved some of the problems men-
tioned in a similar study by Straw et al. [18], in that this
study was designed to control heterogeneities due to the
environment, herd health status, host characteristics and
management conditions inherent at the pig and herd
level to reduce if not eliminate confounding [29,30]. Fur-
thermore, keeping the pigs at one location in a uniform
environment and husbandry eliminated these factors asTable 7 Multilevel regression for overall feed intake of pig in













Constant (β0) 445.0 16.5
Abbreviations: SERONEG Seronegative pigs, SEROPOS Seropositive pigs (not tested fo
VIR2 pigs viral positive between bodyweight 61 kg and 80 kg, VIR3 pigs viral positiv
Growth phase was from 33 kg to 100 kg bodyweight. The model is hierarchical withpotential confounders in our model. Our models also
proved to have a relatively high explanatory ability on
the variance as the achieved adjusted R2 were 51%
(ADG), 59% (FCE), 51% (Age100 kg), 66% (ADFI) and
20% (OFI), which were proportions of variation that
were explained by the predictors in the models. The lon-
gitudinal nature of the data for each pig allowed the statis-
tical models to account for changes to FCE, ADFI andfected with influenza A(H1N1)pdm09 virus
P values 95% CI
<0.001 2.8 9.0
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e between bodyweight 81 kg and 100 kg.
two levels; pig (n = 1955) and herd (n = 43).
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phase by including growth phase (GF) as a dummy vari-
able in the statistical models thus controlling for con-
founding due to normal variation of feed conversion
efficiency and daily feed intake with stage in growth phase.
Our samples of 1955 pigs included pigs tested at the
station over four years from 2009 and 2012. We saw in
our models that birthdate was a significant covariate be-
cause pigs born later had better growth performance as a
result of improvement over time due to genetic selection,
improved feed, and management improvement. Pigs be-
longing to the five infection status groups were dispropor-
tionately distributed over these four years since all 194
virus positive pigs were sampled in a single year (2011)
while 560 pigs from seronegative and seropositive group
were sampled in 2009 and 2010. Despite these dispropor-
tions, we were able to account for the marginal effects at-
tributed to improvement over time by including birthdate
as a covariate in our multi-level regression models. This
allowed us to increase the study sample and hence the
power of our study.
As normal occurrence and also seen in our study, the
feed intake increases and FCE declines as a pig grows. Des-
pite the reduced FCE in an older pig, its ADG is still higher
because it consumes a higher amount of feed than the
younger pig. Hypothetically, if older pigs ate the same
amount of feed as the younger pigs, their ADG would be
lower because of a reduced FCE as depicted by the coeffi-
cients of GF for outcome ADG and FCE in Tables 2, 3 and
4. This is also depicted in our marginal plots at Figures 2
and 3. This again underlines the importance of having
growth phase as a dummy variable in our models to ensure
comparisons of our outcomes between the 5 infection-
status groups were valid because comparisons between
groups were made in the same growth phase.
The coefficients of covariates breed, birthdate, growth
phase and average daily feed intake in all five models
were useful for the validation of our statistical models by
comparing their values with other sources of pig per-
formance data. An improbable coefficient would have
raised a red flag on the models.
All five outcomes in our models were correlated. The
calculation of feed conversion efficiency was based on
average daily feed intake and average daily growth re-
cordings. They in turn determined the remaining 2 out-
comes on overall growth performance, which were age
of pig at 100 kg bodyweight and overall feed intake.
These latter 2 outcomes on overall growth performance
are especially useful in evaluating economic conse-
quences of the infection for farmers. Cost of extra feed
and a delay in getting the pig to the market will lead to
higher overheads (feed and veterinary costs) and lower
income for the farmer since fewer pigs are sold in the
fixed time period. We found that pigs infected whenthey were young (33 kg - 60 kg) required an additional
8 kg feed and were 1.6 days slower in reaching 100 kg
bodyweight. Farmers can estimate the added operational
costs if they know that their pigs were infected at a young
or older age.
In other parts of the world, SIVs seldom act alone, but
with concurrent infections to cause porcine respiratory
disease complex where SIVs are the most common pri-
mary pathogens [1,2,7,31,32]. Hypothetically, the severity
of influenza A(H1N1)pdm09 virus infection in terms of
growth performance would be aggravated by concurrent
infection of these other respiratory pathogens [7]. On the
other hand, these pigs could also be protected from influ-
enza A(H1N1)pdm09 virus infection because of presence
of protective immunity against other strains of SIVs [27].
Conclusions
Our study shows that influenza A(H1N1)pdm09 virus
infection in Norwegian pigs differs from the classical
swine influenza experienced in other parts of the world
because of the low morbidity and mild clinical signs. Al-
though largely subclinical, the infection in Norwegian
pigs did experience adverse effects on growth performance
primarily because of reduced FCE. This is an important
consideration for farmers because it directly influences the
profitability of the pig production in terms higher over-
heads in terms of feed costs and additional time needed
for infected pigs to reach market weight leading to lower
income. The adverse effects were more severe and lasted
longer in pigs infected at a younger age.
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